MAPS : Multidisciplinary Association for Psychedelic Studies

 
Medical Marijuana





MAPS is the only organization working to demonstrate the safety and efficacy of botanical marijuana as a prescription medicine for specific medical uses to the satisfaction of the U.S. Food and Drug Administration.

Our efforts to initiate medical marijuana research have been hindered by the National Institute on Drug Abuse (NIDA) and the Drug Enforcement Administration (DEA) since our founding in 1986.

NIDA's monopoly on the supply of marijuana for research and the DEA's refusal to allow researchers to grow their own has paralyzed medical marijuana research, and for over ten years MAPS has been involved in legal struggles against the DEA to end this situation.

Mission Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. Work MAPS furthers its mission by: Developing psychedelics and marijuana into prescription medicines Training therapists and working to establish a network of treatment centers Supporting scientific research into spirituality, creativity, and neuroscience Educating the public honestly about the risks and benefits of psychedelics and marijuana.  Vision MAPS envisions a world where psychedelics and marijuana are safely and legally available for beneficial uses, and where research is governed by rigorous scientific evaluation of their risks and benefits.

Link:
 http://www.maps.org/research/mmj/